Recent Decisions

Logo CBS News
PoliticsBy Cbs News2022-12-07 03:41:06
John Dickerson discusses the fraud verdict against the Trump Organization, the Georgia Senate runoff, and the Supreme Court case involving the independent...

Logo Benzinga
PoliticsBy Bhavik Nair2022-12-08 01:21:04
The U.S. Securities and Exchange Commission (SEC) is set to vote on whether to propose some of the biggest changes to the equity markets in close to two...

Logo U.S. News & World Report
PoliticsBy Associated Press2022-12-07 21:04:34
Eds: The Wisconsin editorial roundup will not move this week due to a lack of editorials of state-wide interest. We will resume the roundup at its normal...

Logo American Banker
Business / FinanceBy Editorial Staff2022-12-07 14:25:33
In global news this week, the EU cracks down on buy now/pay later; France conducts digital currency test, Tencent launches cross-border payments, and other...

Logo Bloomberg
PoliticsBy Morwenna Coniam2022-12-07 14:25:18
Northern Irish politicians failed to form a government for a fifth time since May’s election, compounding a political impasse triggered by a dispute over the...

Logo The New York Times
Business / FinanceBy David Mc Cabe2022-12-07 10:00:36
As the Federal Trade Commission prepares to face off in court against Meta over a V.R. start-up deal, the agency is testing a novel argument as part of a...

Logo U.S. News & World Report
PoliticsBy Associated Press2022-12-07 20:10:21
Eds: The South Dakota editorial roundup will not move this week due to a lack of editorials of state-wide interest. We will resume the roundup at its normal...

Logo Nasdaq
Business / FinanceBy Mt Newswires2022-12-07 14:13:46
Financial stocks were declining pre-bell Wednesday as the Financial Select Sector SPDR Fund ( XLF ) was 0.3% lower recently. The Direxion Daily Financial...

Logo Fortune
Business / FinanceBy Matthew Perrone2022-12-07 21:39:09
The FDAs drug center has granted just 10 accelerated approvals year to date.

Logo GlobeNewswire
TechnologyPress Release2022-12-07 03:49:00
NEW ORLEANS, Dec. 06, 2022 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 3, 2023 to...

Logo Nasdaq
Business / FinanceBy Guest Contributors2022-12-07 15:59:24
By Eddie Hui, Chief Operating Officer of MetaComp Far from the optimism we saw in 2021, the crypto industry has been singing a different tune after a...

Logo PR Newswire
NEW YORK, Dec. 7, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TuSimple Holdings Inc.. Shareholders who purchased...

Logo CNBC
Business / FinanceBy Krystal Hur2022-12-07 16:52:07
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. Buy...

Logo Nasdaq
Business / FinanceBy The Motley Fool2022-12-07 17:15:00
Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more

Logo CBS News
PoliticsBy Cbs News2022-12-07 13:40:18
The U.S. Supreme Court will hear arguments in Moore v. Harpe, a case that focuses on what the U.S. Constitution says about the state's involvement in...

Logo GlobeNewswire
Disclosure13 /2022 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with...

Logo PR Newswire
LOS ANGELES, Dec. 7, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the...

Logo Channel NewsAsia
Business / FinanceBy Cna2022-12-07 14:31:51
Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide Best News Website or Mobile Service Digital Media Awards Worldwide PARIS : The...

Logo GlobeNewswire
NEW YORK, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

Logo WJXT
PoliticsBy Matthew Perrone2022-12-07 05:01:08
WASHINGTON Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from...